Shardul Amarchand Mangaldas & Co. advised Novo Holdings A/S on its investment in MedGenome Inc.
The leading law firm in India, Shardul Amarchand Mangaldas & Co. advised Novo Holdings A/S on its investment in MedGenome Inc. as part of the company’s USD 47.5 million Series E funding round, co-led by Novo Holdings A/S and Maj Invest.
The investment will support MedGenome Inc. in expanding its genomics and integrated diagnostics solutions across India and other emerging markets, focusing on early detection and targeted disease management through affordable genetic and integrated diagnostics tools.
The SAM team provided end-to-end legal support on the transaction. The transaction team was led by Nishant Singh (Partner), and included Saksham Madan (Principal Associate) and Charith Reddy (Senior Associate).
Other parties involved in the transaction included Sofina Ventures S.A., Maj Invest Minorities II K/S, and MedGenome Inc., with Argus Partners advising MedGenome Inc.
Click to know more about Shardul Amarchand Mangaldas & Co.
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at [email protected] or call us on +91 8879634922.